Skip to content

Study · Animal study (in vivo) · mouse · 2001

1 result

[Immunotropic and immunogenic properties of Burkholderia pseudomallei surface and membrane antigens].

Piven' NN, Rybkin VS, Plekhanova NG, Zhukova SI, Viktorov DV, Avrorova IV, Demediuk EA, Drefs NM, Popov SF

Zhurnal mikrobiologii, epidemiologii i immunobiologii1 Jan 2001

PMID11236497 (opens in a new tab)PepBankPUB-11236497
Publisher pageAsk about this study
Jump to 1 result

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

1 result from studies that gave the peptide. No result from this study comes from people.

  1. 01AnimalAnimal study (in vivo)Efficacy outcome

    In infected mice, adding Bromantan to antigenic complexes enhanced the protective effect of immunization.

    In plain wordsIn mice, antigenic complexes with Bromantan increased protection compared with antigenic complexes alone.

    Peptide
    Bromantane
    Outcome
    IncreaseProtective effect of immunization
    Study

    mousen: not reported in source

    mice infected with virulent B. pseudomallei
    Comparator
    Antigenic complexes without Bromantan
    Outcome group
    Cancer biomarkers and prognosis · Immune and inflammation
    Studied dose
    Dose not stated

    Source sentences

    Summary
    Complex immunization with the antigenic complexes under study, introduced in combination with the immunomodulating agent Bromantan, was shown to enhance the protective effect.
    1 context sentence
    Summary · context
    Some antigenic fractions (B, C, C1, H) showed perceptible protective activity (25-60%) in experiments on mice infected with B. pseudomallei virulent strain.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    21 Oct 2026, 15:58 UTC

    Study results updated

  2. Version 1

    21 Oct 2026, 12:50 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.